Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you find your favorite podcasts. After completing $300 billion in healthcare deals over several decades, there is ...
Stock of the Day: Howard Hughes Holdings whipsaws as Bill Ackman revises his plan to create the next Berkshire Hathaway
Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...
Bausch Health Defeats Shareholder Suit Over Spinoff, Drug Patent
Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.